Lomustine (CCNU) for Dogs and Cats: How It Works, Side Effects, Monitoring, and Real-World Use in Cancer Treatment

By Dr Duncan Houston

Cancer is one of the most challenging diagnoses in veterinary medicine, not just because of the disease itself, but because of the decisions that follow. Treatment is rarely about a single drug or a single plan. It is about balancing control of the disease, quality of life, side effects, and realistic expectations.

Lomustine, commonly referred to as CCNU, is one of the most important chemotherapy drugs used in veterinary oncology. It is particularly valuable in cases where tumors are aggressive, systemic, or difficult to treat surgically.

In practice, lomustine is not a “light” medication. It is a powerful chemotherapy agent with real benefits and real risks. Used correctly, it can significantly improve outcomes in certain cancers. Used without proper monitoring, it can cause serious complications.

This guide explains how lomustine works, when it is used, what to expect during treatment, how to monitor safely, and how to think about it from a real clinical perspective.

Quick Answer

Lomustine (CCNU) is a chemotherapy drug used in dogs and cats to treat cancers such as lymphoma, mast cell tumors, and certain brain tumors. It works by damaging cancer cell DNA and preventing replication. It is usually given at intervals (often every 3 to 6 weeks) and requires careful monitoring, particularly of white blood cells and liver function, as bone marrow suppression and liver toxicity are the most important risks.

What Is Lomustine?

Lomustine is a nitrosourea chemotherapy agent.

It is part of a class of drugs known for:

• strong anti-cancer activity

• ability to penetrate tissues effectively

• activity against certain resistant tumors

• ability to cross the blood-brain barrier

Why that last point matters

Many chemotherapy drugs do not reach the brain effectively. Lomustine does, which makes it particularly useful in:

• brain tumors

• central nervous system involvement

• certain metastatic cancers

How Lomustine Works

Lomustine works by damaging DNA within cells.

Specifically, it:

• binds to DNA

• creates cross-links in DNA strands

• prevents replication and repair

• leads to cell death

Why it targets cancer cells

Cancer cells divide rapidly, which makes them more vulnerable to DNA damage.

However:

• normal cells that divide quickly can also be affected

• this is where side effects come from

What Types of Cancer Is Lomustine Used For?

Lomustine is commonly used in veterinary oncology for:

Lymphoma

Especially in cases that:

• have relapsed

• are resistant to first-line protocols

Mast cell tumors

Particularly:

• high-grade tumors

• metastatic disease

• non-resectable tumors

Brain tumors

Because it crosses the blood-brain barrier.

Other uses

• histiocytic sarcoma

• some soft tissue sarcomas

• other aggressive or refractory cancers

Real-World Clinical Use

Lomustine is rarely used in isolation.

It is often part of:

• multi-drug chemotherapy protocols

• rescue protocols after first-line failure

• palliative treatment plans

Clinical reality

The goal is not always cure. In many cases, the goal is:

• extending survival time

• improving quality of life

• reducing tumor burden

• slowing disease progression

How Lomustine Is Given

Lomustine is typically:

• given orally as a capsule

• administered at defined intervals

Common dosing interval

• every 3 to 6 weeks

This interval is not arbitrary.

It allows time for:

• bone marrow recovery

• assessment of response

• monitoring of side effects

Important principle

Lomustine is not given daily. It is given in cycles to balance effectiveness and safety.

Why Monitoring Is Critical

This is one of the most important parts of using lomustine properly.

Bone marrow suppression

Lomustine can reduce:

• white blood cells

• red blood cells

• platelets

When this happens

Typically:

• 7 to 14 days after dosing

• sometimes later depending on the patient

Why it matters

Low white blood cells increase infection risk.
Low platelets increase bleeding risk.

Liver Toxicity: The Other Major Risk

Lomustine is also known for cumulative liver toxicity.

What this means

• liver damage may develop over time

• risk increases with repeated doses

• damage can be progressive

Monitoring includes

• liver enzyme testing (e.g. ALT)

• regular bloodwork before each dose

Clinical insight

Liver toxicity is one of the main reasons lomustine protocols are adjusted or stopped.

How Serious Are the Side Effects?

Mild

• mild lethargy

• reduced appetite

• transient nausea

These are often manageable.

Moderate

• vomiting

• diarrhea

• noticeable drop in appetite

• mild blood count changes

These require monitoring and sometimes dose adjustment.

Severe

• significant bone marrow suppression

• infection risk

• bleeding risk

• marked lethargy

These require immediate veterinary attention.

Critical

• severe liver damage

• septic complications from low white cells

• life-threatening complications

These are uncommon but serious.

What It Looks Like When Lomustine Is Working

Positive signs may include:

• reduction in tumor size

• improved energy

• improved appetite

• reduced clinical signs

Clinical reality

Response varies widely depending on:

• tumor type

• stage

• overall health

What It Looks Like When It Is Not Working

• no tumor response

• disease progression

• worsening clinical signs

Decision point

Treatment plans may need:

• adjustment

• combination therapy

• change in protocol

Drug Interactions and Combination Therapy

Lomustine is often used alongside other treatments, but combinations must be managed carefully.

Increased risk when combined with:

• other chemotherapy drugs

• immunosuppressive medications

• corticosteroids

Why this matters

Combined effects can increase:

• bone marrow suppression

• infection risk

Special Safety Considerations

Handling precautions

Lomustine is a chemotherapy drug.

• gloves should be worn when handling

• avoid direct contact with capsules

• avoid exposure to pet waste after dosing

Why this matters

Trace amounts of drug may be present in:

• urine

• feces

• saliva

When Should Lomustine Not Be Used?

Avoid or use with extreme caution in:

• pregnant animals

• breeding animals

• patients with severe liver disease

• patients with existing bone marrow suppression

What To Expect During Treatment

First few days after dosing

• usually minimal immediate effects

1 to 2 weeks after dosing

• possible drop in blood cell counts

• this is the critical monitoring period

Between cycles

• recovery phase

• reassessment

• planning next dose

When Is This an Emergency?

Seek urgent veterinary care if your pet shows:

• fever

• lethargy

• refusal to eat

• bleeding

• pale gums

• vomiting that does not stop

• signs of infection

These may indicate:

• bone marrow suppression complications

• systemic illness

Common Mistakes

• not monitoring bloodwork

• missing follow-up tests

• assuming no side effects means no risk

• continuing treatment despite worsening liver values

• not adjusting protocols when needed

• underestimating delayed side effects

FAQ

How often is lomustine given?

Usually every 3 to 6 weeks, depending on the protocol.

How quickly does it work?

Response varies. Some improvement may be seen within weeks, but depends on cancer type.

Is lomustine curative?

Usually not. It is often used to control disease rather than cure it.

What is the biggest risk?

Bone marrow suppression and liver toxicity.

Why is bloodwork so important?

It detects problems before they become dangerous.

Can pets tolerate lomustine well?

Many do, but careful monitoring is essential.

Final Thoughts

Lomustine is a powerful and valuable chemotherapy drug in veterinary medicine, particularly for difficult cancers such as lymphoma, mast cell tumors, and brain tumors.

But it is not a simple medication. It requires careful dosing, careful monitoring, and a clear understanding of risks and goals.

The best outcomes come from structured treatment plans, regular reassessment, and balancing disease control with quality of life.

If your pet has been diagnosed with cancer and you are unsure whether lomustine is appropriate, or you need help understanding risks, monitoring, or expectations, ASK A VET™ can help guide you through the decision with clear, practical veterinary advice tailored to your pet.